SEC Comment Letter for Pulmatrix, Inc. (PULM) (CIK 0001574235) (PULM) — Mar 19, 2018
Pulmatrix, Inc. (PULM) (CIK 0001574235)
Date: March 19, 2018 · CIK: 0001574235 · Accession: 0000000000-18-008361
AI Filing Summary & Sentiment
File numbers found in text: 333-223630
Letter
March 16, 2018 Robert W. Clarke Chief Executive Officer and President Pulmatrix, Inc. 99 Hayden Avenue, Suite 390 Lexington, MA 02421 Re:Pulmatrix, Inc. Registration Statement on Form S-1 Filed March 13, 2018 File No. 333-223630 Dear Dr. Clarke: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jeffrey Gabor at 202-551-2544 with any questions. Division of Corporation Finance Office of Healthcare & Insurance cc: Rick Werner
Show Raw Text
March 16, 2018
Robert W. Clarke
Chief Executive Officer and President
Pulmatrix, Inc.
99 Hayden Avenue, Suite 390
Lexington, MA 02421
Re:Pulmatrix, Inc.
Registration Statement on Form S-1
Filed March 13, 2018
File No. 333-223630
Dear Dr. Clarke:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jeffrey Gabor at 202-551-2544 with any questions.
Division of Corporation Finance
Office of Healthcare & Insurance
cc: Rick Werner